Hakutulokset - Helen Cox

Tarkenna hakua
  1. 1
    Drug-resistant tuberculosis: challenges and opportunities for diagnosis and treatment

    Drug-resistant tuberculosis: challenges and opportunities for diagnosis and treatment Tekijä Anastasia Koch, Helen Cox, Valerie Mizrahi

    Julkaistu 2018
    Hae kokoteksti
    Revisão
    Lisää suosikkeihin
    Tallennettuna:
  2. 2
    Long term efficacy of DOTS regimens for tuberculosis: systematic review

    Long term efficacy of DOTS regimens for tuberculosis: systematic review Tekijä Helen Cox, Martha G. Morrow, Peter Deutschmann

    Julkaistu 2008
    Hae kokoteksti Hae kokoteksti
    Revisão
    Lisää suosikkeihin
    Tallennettuna:
  3. 3
    THYMUS-DERIVED LYMPHOCYTES PRODUCE AN IMMUNOLOGICALLY SPECIFIC MACROPHAGEARMING FACTOR

    THYMUS-DERIVED LYMPHOCYTES PRODUCE AN IMMUNOLOGICALLY SPECIFIC MACROPHAGEARMING FACTOR Tekijä Robert L. Evans, C. K. Grant, Helen Cox, Kathleen Steele, Peter Alexander

    Julkaistu 1972
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  4. 4
    Outcomes of clofazimine for the treatment of drug-resistant tuberculosis: a systematic review and meta-analysis

    Outcomes of clofazimine for the treatment of drug-resistant tuberculosis: a systematic review and meta-analysis Tekijä Teesta Dey, Grania Brigden, Helen Cox, Zara Shubber, Graham Cooke, Nathan Ford

    Julkaistu 2012
    Hae kokoteksti Hae kokoteksti
    Revisão
    Lisää suosikkeihin
    Tallennettuna:
  5. 5
    The Beijing genotype and drug resistant tuberculosis in the Aral Sea region of Central Asia

    The Beijing genotype and drug resistant tuberculosis in the Aral Sea region of Central Asia Tekijä Helen Cox, Tanja Kubica, Daribay Doshetov, Yared Kebede, Sabine Rüsch-Gerdess, Stefan Niemann

    Julkaistu 2005
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  6. 6
    A systematic review and meta-analysis of the efficacy and safety of<i>N</i>-acetylcysteine in preventing aminoglycoside-induced ototoxicity: implications for the treatment of multidrug-resistant TB

    A systematic review and meta-analysis of the efficacy and safety of<i>N</i>-acetylcysteine in preventing aminoglycoside-induced ototoxicity: implications for the treatment of multi... Tekijä Katharina Kranzer, Wael Elamin, Helen Cox, James A. Seddon, Nathan Ford, Francis Drobniewski

    Julkaistu 2015
    Hae kokoteksti Hae kokoteksti
    Revisão
    Lisää suosikkeihin
    Tallennettuna:
  7. 7
    Recent controversies about <scp>MDR</scp> and <scp>XDR‐TB</scp>: <scp>G</scp>lobal implementation of the <scp>WHO</scp> shorter <scp>MDR‐TB</scp> regimen and bedaquiline for all with <scp>MDR‐TB</scp>?

    Recent controversies about <scp>MDR</scp> and <scp>XDR‐TB</scp>: <scp>G</scp>lobal implementation of the <scp>WHO</scp> shorter <scp>MDR‐TB</scp> regimen and bedaquiline for all wi... Tekijä Keertan Dheda, Helen Cox, Aliasgar Esmail, Sean Wasserman, Kwok Chiu Chang, Christoph Lange

    Julkaistu 2017
    Hae kokoteksti Hae kokoteksti
    Revisão
    Lisää suosikkeihin
    Tallennettuna:
  8. 8
    Patients' costs associated with seeking and accessing treatment for drug-resistant tuberculosis in South Africa

    Patients' costs associated with seeking and accessing treatment for drug-resistant tuberculosis in South Africa Tekijä Lebogang Ramma, Helen Cox, Lynne Wilkinson, Nicola Foster, Lucy Cunnama, Anna Vassall, Edina Sinanovic

    Julkaistu 2015
    Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  9. 9
    Infection Control for Drug-Resistant Tuberculosis: Early Diagnosis and Treatment Is the Key: Table 1.

    Infection Control for Drug-Resistant Tuberculosis: Early Diagnosis and Treatment Is the Key: Table 1. Tekijä Gilles Van Cutsem, Petros Isaakidis, Jason E. Farley, E. Nardell, Grigory Volchenkov, Helen Cox

    Julkaistu 2016
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  10. 10
    Destined to die in hospital? Systematic review and meta-analysis of place of death in haematological malignancy

    Destined to die in hospital? Systematic review and meta-analysis of place of death in haematological malignancy Tekijä Debra Howell, Eve Roman, Helen Cox, Alexandra Smith, Russell Patmore, Anne C Garry, Martin Howard

    Julkaistu 2010
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  11. 11
    Sequence Analyses of Just Four Genes To Detect Extensively Drug-Resistant <i>Mycobacterium tuberculosis</i> Strains in Multidrug-Resistant Tuberculosis Patients Undergoing Treatment

    Sequence Analyses of Just Four Genes To Detect Extensively Drug-Resistant <i>Mycobacterium tuberculosis</i> Strains in Multidrug-Resistant Tuberculosis Patients Undergoing Treatmen... Tekijä Silke Feuerriegel, Helen Cox, Nana Zarkua, Hamraev A. Karimovich, Kai Braker, Sabine Rüsch–Gerdes, Stefan Niemann

    Julkaistu 2009
    Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  12. 12
    “A very humiliating illness”: a qualitative study of patient-centered Care for Rifampicin-Resistant Tuberculosis in South Africa

    “A very humiliating illness”: a qualitative study of patient-centered Care for Rifampicin-Resistant Tuberculosis in South Africa Tekijä Jennifer Furin, Marian Loveday, Sindisiwe Hlangu, Lindy Dickson-Hall, S. Le Roux, Mark P. Nicol, Helen Cox

    Julkaistu 2020
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  13. 13
    Risk of Acquired Drug Resistance during Short-Course Directly Observed Treatment of Tuberculosis in an Area with High Levels of Drug Resistance

    Risk of Acquired Drug Resistance during Short-Course Directly Observed Treatment of Tuberculosis in an Area with High Levels of Drug Resistance Tekijä Helen Cox, Stefan Niemann, Г. Р. Исмайлов, Darebay Doshetov, Javier Orozco, Lucie Blok, Silke Gerdes, Yenew Kebede

    Julkaistu 2007
    Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  14. 14
    A Connective Tissue Disorder Caused by Mutations of the Lysyl Hydroxylase 3 Gene

    A Connective Tissue Disorder Caused by Mutations of the Lysyl Hydroxylase 3 Gene Tekijä Antti M. Salo, Helen Cox, Peter Farndon, Celia Moss, Helen Grindulis, Maija Risteli, Simon P. Robins, Raili Myllylä

    Julkaistu 2008
    Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  15. 15
    Opportunities from a new disease for an old threat: Extending COVID-19 efforts to address tuberculosis in South Africa

    Opportunities from a new disease for an old threat: Extending COVID-19 efforts to address tuberculosis in South Africa Tekijä Marian Loveday, Helen Cox, Denise Evans, Jennifer Furin, Norbert Ndjeka, Muhammad Osman, K Naidoo for the National TB Think Tank 'Optim

    Julkaistu 2020
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  16. 16
    Multidrug-Resistant Tuberculosis Treatment Outcomes in Karakalpakstan, Uzbekistan: Treatment Complexity and XDR-TB among Treatment Failures

    Multidrug-Resistant Tuberculosis Treatment Outcomes in Karakalpakstan, Uzbekistan: Treatment Complexity and XDR-TB among Treatment Failures Tekijä Helen Cox, Stobdan Kalon, Sholpan Allamuratova, Vinciane Sizaire, Zinaida Tigay, Sabine Rüsch–Gerdes, Hamraev A. Karimovich, Yared Kebede, Clair Mills

    Julkaistu 2007
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  17. 17
    Impact of reduced hospitalisation on the cost of treatment for drug-resistant tuberculosis in South Africa

    Impact of reduced hospitalisation on the cost of treatment for drug-resistant tuberculosis in South Africa Tekijä Edina Sinanovic, Lebogang Ramma, Anna Vassall, Valderílio Feijó Azevedo, Lynne Wilkinson, Norbert Ndjeka, Kerrigan McCarthy, Gavin Churchyard, Helen Cox

    Julkaistu 2015
    Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  18. 18
    Emergence of Extensive Drug Resistance during Treatment for Multidrug-Resistant Tuberculosis

    Emergence of Extensive Drug Resistance during Treatment for Multidrug-Resistant Tuberculosis Tekijä Helen Cox, C Sibilia, Silke Feuerriegel, Stobdan Kalon, Jonathan A. Polonsky, Atadjan Khamraev, Sabine Rüsch–Gerdes, Clair Mills, Stefan Niemann

    Julkaistu 2008
    Hae kokoteksti Hae kokoteksti
    Carta
    Lisää suosikkeihin
    Tallennettuna:
  19. 19
    Preventive Therapy for Child Contacts of Multidrug-Resistant Tuberculosis: A Prospective Cohort Study

    Preventive Therapy for Child Contacts of Multidrug-Resistant Tuberculosis: A Prospective Cohort Study Tekijä James A. Seddon, A C Hesseling, Heather Finlayson, Katherine Fielding, Helen Cox, Jennifer Hughes, Peter Godfrey‐Faussett, H. Simon Schaaf

    Julkaistu 2013
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  20. 20
    Impact of Decentralized Care and the Xpert MTB/RIF Test on Rifampicin-Resistant Tuberculosis Treatment Initiation in Khayelitsha, South Africa

    Impact of Decentralized Care and the Xpert MTB/RIF Test on Rifampicin-Resistant Tuberculosis Treatment Initiation in Khayelitsha, South Africa Tekijä Helen Cox, Johnny Daniels, Odelia Muller, Mark P. Nicol, Vivian Cox, Gilles Van Cutsem, Sizulu Moyo, Virginia De Azevedo, Jennifer Hughes

    Julkaistu 2015
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:

Työkalut: